ADMA Biologics - admabiologics.com
A late-stage bio-pharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of certain infectious diseases. Targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. Product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients with or at risk for certain infectious diseases.
ADMA also operates ADMA BioCenters, a FDA-licensed source plasma collection facilities which provide a portion of blood plasma for the manufacture of the Company's lead product candidate RI-002.
WELCOME! —This is a moderated board. No spam, ad hominem attacks or flaming. One warning. Next time you're out, with your posts deleted.